Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone diseaseSonia Vallet, Noopur Raje, A.R. Guimarães et al.|Proceedings of the National Academy of Sciences|2010Cited by 235
MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclastsSonia Vallet, Kenneth C. Anderson|Blood|2007Cited by 150
Pre-Osteoblasts Stimulate Migration of Breast Cancer Cells via the HGF/MET PathwaySonia Vallet, Klaus Podar|PLoS ONE|2016Cited by 24
The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant ChemotherapyDavid D‘Andrea, Marco Moschini, Shahrokh F. Shariat et al.|European Urology Open Science|2022Cited by 14
Favorable impact of PD1/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validationTamara Gassner, Sonia Vallet|Journal for ImmunoTherapy of Cancer|2024Cited by 13